Media & Resources

Filter by

Type
- All types
- Fact Sheets & Publications
- Features
- IAVI Report
- In The News
- Podcasts
- Press Releases
- Scientific Publications
- Vaccine Literacy Library
- Videos
Health area
- Clinical trials(2)
- COVID-19(58)
- Ebola Sudan(40)
- EID(2)
- Emerging infectious diseases(1)
- Global access(11)
- HIV(379)
- Lassa fever(30)
- Lassa virus(1)
- Malaria(1)
- Marburg(18)
- Marburg virus(1)
- Other(102)
- Sexually transmitted infections(1)
- Snakebite(6)
- Sudan virus(8)
- TB(1)
- Tuberculosis(77)
- Vaccine research(14)
Location
- Africa(230)
- Europe(30)
- Global(445)
- India(15)
- Japan(1)
- United States(26)
- US(4)
- USA(1)
- Washington(1)
Topic
- Access(19)
- Antibodies(80)
- Capacity strengthening(13)
- Clinical trials(106)
- Community engagement(40)
- Emerging infectious diseases(1)
- Epidemiology(43)
- Funding(38)
- Germline targeting(5)
- Global access(8)
- Key populations(8)
- Pandemic preparedness(30)
- Partnerships(39)
- People(56)
- Policy and advocacy(44)
- Regulatory pathways(6)
- Social-behavioral research(3)
- Vaccine research(216)
Year
Journal
- Acta Crystallogr. D Biol. Crystallogr.(1)
- Addict Behav Rep(1)
- Afr J Lab Med(1)
- AIDS(41)
- AIDS Behav(9)
- AIDS Behav.(1)
- AIDS Care(5)
- AIDS Patient Care STDS(1)
- AIDS Res Hum Retroviruses(25)
- AIDS Res Ther(1)
- Am J Mens Health(1)
- Am J Public Health(1)
- Anal. Biochem.(1)
- Angew. Chem. Int. Ed. Engl.(2)
- Ann. Hum. Genet.(1)
- Ann. Intern. Med.(1)
- Ann. N. Y. Acad. Sci.(1)
- Ann. Oncol.(1)
- Annu. Rev. Immunol.(1)
- Annu. Rev. Med.(1)
- Biochemistry(3)
- Biologicals(3)
- Biomolecules(1)
- Biores Open Access(1)
- bioRxiv(1)
- Biotechnol Bioeng(2)
- Biotechnol J(1)
- Blood(1)
- BMC Biochem.(1)
- BMC Health Serv Res(2)
- BMC Immunol.(1)
- BMC Infect Dis(6)
- BMC Infect Dis.(1)
- BMC Med(2)
- BMC Med Educ(1)
- BMC Med Res Methodol(1)
- BMC Public Health(7)
- BMC Res Notes(1)
- BMC Womens Health(2)
- BMJ Glob Health(1)
- BMJ Open(2)
- Br. Med. Bull.(1)
- Bull. World Health Organ.(1)
- Campbell Syst Rev(1)
- Cell(10)
- Cell Chem Biol(1)
- Cell Host Microbe(2)
- Cell Rep(15)
- Chem Asian J(1)
- Chem. Biol.(1)
- Chem. Commun. (Camb.)(1)
- Clin Infect Dis(4)
- Clin. Vaccine Immunol.(3)
- Cogent Med(1)
- Contemp Clin Trials Commun(1)
- Contraception(3)
- Cult Health Sex(1)
- Curr Opin HIV AIDS(5)
- Curr. HIV Res.(1)
- Curr. Opin. Biotechnol.(1)
- Curr. Opin. Immunol.(3)
- Curr. Opin. Mol. Ther.(1)
- Curr. Opin. Struct. Biol.(1)
- Curr. Pharm. Des.(1)
- Curr. Top. Microbiol. Immunol.(1)
- Current Opinion in HIV and AIDS(1)
- East Afr Med J(2)
- eBioMedicine(1)
- Elife(1)
- Epidemiol. Infect.(1)
- Epidemiology(1)
- Eur. J. Immunol.(2)
- Expert Rev Vaccines(7)
- FASEB J.(1)
- Front Cell Infect Microbiol(1)
- Front Immunol(14)
- Front Microbiol(2)
- Front Public Health(1)
- Front Reprod Health(2)
- Gene Ther.(1)
- Genes Immun.(3)
- Global Health(1)
- Glycobiology(3)
- Health Aff (Millwood)(2)
- Health Policy(1)
- Health Promot Int(1)
- Health Res Policy Syst(1)
- HIV Med(1)
- Hum Vaccin(2)
- Hum Vaccin Immunother(2)
- Hum. Genet.(1)
- Human Vaccines & Immunotherapeutics(1)
- IJID Reg(1)
- Immunity(29)
- Immunol. Rev.(4)
- Indian J Pediatr(2)
- Indian J. Med. Res.(4)
- Int Health(3)
- Int J Epidemiol(2)
- Int J Med Inform(2)
- Int J STD AIDS(4)
- J Adv Manuf Process(1)
- J Antimicrob Chemother(1)
- J Comput Chem(1)
- J Family Med Prim Care(1)
- J HIV AIDS Surveill Epidemiol(1)
- J Immunol(16)
- J Infect Dis(16)
- J Int AIDS Soc(14)
- J Pharm Sci(1)
- J Womens Health (Larchmt)(1)
- J. Acquir. Immune Defic. Syndr.(16)
- J. Am. Chem. Soc.(3)
- J. Am. Soc. Mass Spectrom.(1)
- J. Biol. Chem.(9)
- J. Clin. Invest.(2)
- J. Clin. Microbiol.(1)
- J. Exp. Med.(11)
- J. Gen. Virol.(11)
- J. Hepatol.(1)
- J. Immunol. Methods(9)
- J. Med. Primatol.(1)
- J. Mol. Biol.(6)
- J. Pept. Sci.(1)
- J. Virol.(114)
- J. Virol. Methods(2)
- JCI Insight(1)
- JMIR Res Protoc(1)
- Lancet(12)
- Lancet Glob Health(1)
- Lancet HIV(3)
- Lancet Infect Dis(2)
- lancet microbe(1)
- mBio(3)
- medRxiv(1)
- Methods Mol. Med.(1)
- Microbiol Spectr(2)
- Microorganisms(1)
- Mol Ther Methods Clin Dev(1)
- Mol. Ther.(2)
- Mucosal Immunol(1)
- N. Engl. J. Med.(7)
- Nat Commun(17)
- Nat Immunol(2)
- Nat Med(15)
- Nat Microbiol(2)
- Nat. Biotechnol.(1)
- Nat. Chem. Biol.(1)
- Nat. Immunol.(5)
- Nat. Rev. Immunol.(1)
- Nat. Rev. Microbiol.(1)
- Nat. Struct. Mol. Biol.(4)
- Nature(20)
- npj Vaccines(1)
- Nucleic Acids Res.(1)
- Open Forum Infect Dis(2)
- Org. Biomol. Chem.(1)
- Orphanet J Rare Dis.(1)
- Pan Afr Med J(3)
- PDA J Pharm Sci Technol(1)
- Pharmaceut Med(1)
- Pharmacoeconomics(2)
- PLoS Glob Public Health(6)
- PLoS Med.(5)
- PLoS Negl Trop Dis(1)
- PLoS One(84)
- PLoS Pathog(36)
- Proc Natl Acad Sci U S A(30)
- Proteins(1)
- Proteomics(2)
- Rapid Commun. Mass Spectrom.(1)
- Res Involv Engagem(1)
- Retrovirology(13)
- Rev. Med. Virol.(1)
- S. Afr. Med. J.(1)
- Sci Adv(2)
- Sci Immunol(2)
- Sci Rep(8)
- Sci Transl Med(9)
- Science(35)
- Sex Health(1)
- Sex Transm Dis(4)
- Sex Transm Infect(12)
- Southeast Asian J. Trop. Med. Public Health(1)
- Springerplus(1)
- Structure(3)
- Stud Fam Plann(1)
- Syst Rev(1)
- Ther Adv Vaccines(1)
- Top HIV Med(1)
- Toxins(1)
- Trends Microbiol.(1)
- Trends Parasitol(1)
- Trop Dis Travel Med Vaccines(1)
- Trop. Med. Int. Health(7)
- Vaccine(32)
- Vaccines (Basel)(3)
- Virology(36)
- Viruses(1)
- Wellcome Open Res(1)
- Women's Health (Lond)(1)
Publication
- AARP(1)
- ABC 10 News in San Diego,(1)
- ABC News(1)
- ABCNEWS(1)
- AFP News(1)
- AIDSmap(1)
- ANI(1)
- Apna Radio 96.9 fm(1)
- AVAC(1)
- BBC(1)
- BioSpace,(1)
- BioWorld,(1)
- Bloomberg(4)
- Bloomberg Businessweek(1)
- BNN Bloomberg(1)
- Business Daily(1)
- Business Insider(2)
- Center for Global Development(1)
- CEPI(2)
- CGTN(1)
- Chemical & Engineering News(1)
- CIDRAP(4)
- Clinical Trials Arena(2)
- CNBC(1)
- CNN(4)
- CNN International(1)
- Contagion Live(1)
- Cope,(1)
- CSIS(1)
- CSIS Global Health Policy Center(1)
- Daily Mail(1)
- Daily Maverick(1)
- Daily Nation(2)
- Devex(6)
- Drug Discovery & Development,(1)
- Ebru TV (video)(1)
- Economic Times(1)
- El Confidencial(1)
- El Español,(1)
- El Global,(1)
- El País(2)
- EndPoints News(1)
- Es Radio Albacete,(1)
- ETHealthWorld (video)(1)
- EU Observer(1)
- European Commission(1)
- Fierce Pharma,(1)
- Financial Times(1)
- Fox News,(1)
- Gates Foundation(1)
- Gavi(7)
- GEN,(1)
- GeneOnline(1)
- Genetic Engineering & Biotechnology News(1)
- Global Health NOW(1)
- Global Health Technologies Coalition(1)
- HCP Live,(1)
- Health Affairs,(1)
- Health Analytics Asia(1)
- Health Policy Watch(2)
- Hutch News Service(1)
- Indian Express(2)
- Inside Precision Medicine(1)
- International Business Times,(1)
- International Development Research Centre(1)
- La Razón(1)
- La Razón,(1)
- La Tribuna de Albacete(1)
- La Voz de Galicia(1)
- Le Monde(1)
- Los Angeles Times(2)
- Managed Healthcare Executive(2)
- Medical New Today(1)
- MedPage Today(1)
- Memorias(1)
- mosaic(1)
- Nasdaq,(1)
- National Geographic(1)
- National Review(1)
- Nature(6)
- Nature Biotechnology(1)
- Nature India(1)
- NBC News(1)
- New Scientist(1)
- News 18 India(1)
- Newsweek(1)
- NIAID(1)
- Nigeria Health Watch(1)
- Nigerian Television Authority(1)
- NPR(1)
- NPR Goats & Soda(1)
- NPR Goats and Soda(1)
- Person Place Thing (podcast)(1)
- PharmaVoice(1)
- Pindula(1)
- Politico(1)
- Popular Science(1)
- Positively Aware(1)
- Posterity Media(1)
- POZ(2)
- Precision Vaccinations,(1)
- ProPatiens(1)
- ProPatients(2)
- Pulse Nigeria(1)
- Refinery 29(1)
- Results UK(1)
- Reuters(2)
- Reuters,(1)
- Rolling Stone(1)
- Salon(2)
- Sayansi Magazine(1)
- SciDevNet,(2)
- Science(9)
- ScienceNews(1)
- Scroll.in(1)
- Spotlight(1)
- Standard(1)
- STAT(7)
- STAT News(13)
- STAT Plus (Subscription Required)(2)
- TechCrunch,(1)
- Telecinco,(2)
- The Advocate(1)
- The Associated Press(1)
- The BMJ(1)
- The Conversation(1)
- The Daily Nation(2)
- The Guardian(2)
- The Guardian Nigeria(2)
- The HILL(3)
- The Indian Express(1)
- THE LANCET(4)
- The New Times(1)
- The New York Times(3)
- The Observer(1)
- The Standard(1)
- The Star(1)
- The Telegraph(4)
- The Voice of America(1)
- The Wall Street Journal(1)
- The Washington Post(2)
- The Wire(2)
- them.(1)
- TIDES Global(1)
- Times of India(2)
- USAID Blog(1)
- Vaccine Insights(1)
- VaccinesToday(1)
- VICE(1)
- Wall Street Journal,(1)
- WebMD(1)
- Weill Cornell(1)
- WIRED(1)
- World Health Organization(2)
- World Pharmaceutical Frontiers(1)
- Yale School of Medicine(1)
- Zendal(1)
Fact sheet & publication type
- Annual Reports(7)
- Community Engagement Resources(15)
- Fact Sheets(12)
- Policy and Advocacy Publications(21)
Keyword search
Clear all

Press Releases

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

April 4, 2024

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate.

Scientific Publications

Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial

Features

World Vaccine Congress 2024 highlights IAVI’s R&D from end to end

March 29, 2024

IAVI leaders to share updates on our emerging infectious disease R&D portfolio and our work to make much-needed vaccines and antibodies globally accessible.

Scientific Publications

HIV envelope trimers and gp120 as immunogens to induce broadly neutralizing antibodies in cows

Scientific Publications

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria

Scientific Publications

Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming

IAVI Report

Don’t Stop Believin’: This year’s HIV vaccine research theme

March 14, 2024

Researchers at CROI discuss progress on the long road to developing an HIV vaccine.

IAVI Report

With syphilis, it’s yesterday once more

March 14, 2024

Infections are at the highest levels since 1950 and fear of antimicrobial resistance is fueling new concerns over this old pathogen.

1…25 262728 29…239 of 239

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial

World Vaccine Congress 2024 highlights IAVI’s R&D from end to end

HIV envelope trimers and gp120 as immunogens to induce broadly neutralizing antibodies in cows

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria

Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming

Don’t Stop Believin’: This year’s HIV vaccine research theme

With syphilis, it’s yesterday once more

Subscription Type